claim
The serotonergic hallucinogen 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) disrupts cortical activity in a regionally-selective manner via 5-HT1A and 5-HT2A receptors, as reported by Riga et al. in Neuropharmacology (2016).

Authors

Sources

Referenced by nodes (2)